Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 31Neoplasms 20Motor Activity 12Lung Neoplasms 7Fatigue 7Colorectal Neoplasms 6Anxiety Disorders 6Stomach Neoplasms 4Polycystic Ovary Syndrome 4Pain, Postoperative 4Pain 4Depression 4Carcinoma, Hepatocellular 4Thyroid Neoplasms 3Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Malnutrition 3Vomiting 2Urinary Incontinence 2Stomatitis 2Rectal Neoplasms 2Peritoneal Neoplasms 2Parasomnias 2Ovarian Neoplasms 2Nausea 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hot Flashes 2Hematologic Neoplasms 2

Interventions

entecavir 3polysaccharide MGN3 1lens intermediate filament proteins 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Rapid Diagnostic Tests 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pneumococcal Vaccines 1Measles-Mumps-Rubella Vaccine 1Lamivudine 1Hypothermia, Induced 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hepatitis B × Control Groups × Clear all
NCT00824707 2016-04-01

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡